BackPluristem Therapeutics Overview

Pluristem Therapeutics Current Cash

Pluristem Therapeutics's current cash is $3.4M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$3.42M

Peer trimmed avg / median

Loading

Pluristem Therapeutics Current Cash History

Loading

Pluristem Therapeutics vs. peers: Current Cash Comparison

Loading

Pluristem Therapeutics Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Pluristem Therapeutics (PSTI) FAQ

Pluristem Therapeutics (PSTI) currently reports a current cash of $3.4M as of March 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Pluristem Therapeutics's current cash history and peer comparisons.

Pluristem Therapeutics's current cash changed from $0 to $3.4M (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Pluristem Therapeutics reported $3.4M in current cash as of March 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $3.4M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Pluristem Therapeutics, and consider following PSTI for alerts when major investors trade the stock.

Pluristem Therapeutics is classified in the Healthcare sector. On current cash, it currently shows $3.4M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PSTI with unrelated industries.